|
|
|
|
Less NHS Beds? - some say yes
Thousands of hospital beds in England should be axed to save money and improve care, the Reform think tank says.The centre right group said in some areas up to a quarter of beds could go, saying that advances in technology and rising rates of conditions like...
|
|
|
OSI Rejects Astellas' Hostile Bid
OSI Pharmaceuticals, Inc.(NASDAQ: OSIP) today announced that its Board of Directors, after careful review and consideration with the assistance of OSI's management and outside legal and financial advisors, has unanimously rejected the unsolicited,...
|
|
|
Revolade (eltrombopag) receives European marketing authorisation for the treatment of chronic immune thrombo
GlaxoSmithKline (GSK) announced today that the European Medicines Agency (EMEA) has granted marketing authorisation for Revolade (eltrombopag), a once-daily oral treatment for adults with chronic immune thrombocytopenic purpura (ITP).1 Revolade is for patients...
|
|
|
AstraZeneca in Indian Generics Deal
AstraZeneca has announced a license and supply agreement with Torrent Pharmaceuticals Ltd.Torrent will supply to AstraZeneca a portfolio of generic medicines for which Torrent already has licenses in a range of countries. Working in partnership with...
|
|
|
Teva UK Limited wins Best Companies Star Status
Teva UK Limited has achieved a One Star Status under the Best Companies Accreditation 2010.Winning the Star Status is a big achievement for Teva in the Companys first attempt at these awards. The results highlighted that Teva scored particularly well in...
|
|
|
Tranzyme PharmaEURs Clinical Results on Ulimorelin (TZP-101) Selected for Oral Presentation at the Distingui
Let the jobs come to you!Tranzyme Pharma announced today that data from the Phase 2 clinical trial of ulimorelin (TZP-101) for the treatment of severe gastroparesis have been selected for an oral presentation at Digestive Disease Week (DDW) 2010 being held...
|
|
|
ERT Launches Centralized Cardiac Safety 2.0: A Revolutionary New Approach to ECG Management in Clinical Trials
Let the jobs come to you!PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings! The information provided on PharmiWeb. ERT Launches Centralized Cardiac...
|
|
|
Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
Let the jobs come to you!Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the topline results of a Phase III trial led by the U.S! Cancer and Leukemia Group B (CALGB) and sponsored by the National...
|
|
|
Robbins Umeda LLP Announces Investigation of Medivation, Inc
Let the jobs come to you!has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by certain officers and di Robbins Umeda LLP Announces Investigation of Medivation, Inc!
|
|
|
Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Medivation, Inc., Announces Class Action La
Let the jobs come to you!Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of a class consisting of all persons or entities who...
|
